CA1095921A — Preparation of gamma-pyrones
Assigned to Danisco Finland Oy · Expires 1981-02-17 · 45y expired
What this patent protects
ABSTRACT OF THE DISCLOSURE Gamma-pyrones, particularly maltol (2-methyl-3-hydr-oxy-4H-pyran-4-one) and ethyl maltol (2-ethyl-3-hydroxy-4H-pyran-4-one) are prepared by hydrolyzing certain pyran inter-mediates prepared by reacting furfuryl alcohols, particularly 1(2-furyl…
USPTO Abstract
ABSTRACT OF THE DISCLOSURE Gamma-pyrones, particularly maltol (2-methyl-3-hydr-oxy-4H-pyran-4-one) and ethyl maltol (2-ethyl-3-hydroxy-4H-pyran-4-one) are prepared by hydrolyzing certain pyran inter-mediates prepared by reacting furfuryl alcohols, particularly 1(2-furyl)-1-ethanol, in aqueous solution with a halogen-con-taining oxidant. Novel 4-halo-dihydropyran intermediates and the preparation thereof are also disclosed.
Drugs covered by this patent
- Ferriprox (DEFERIPRONE) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.